Effect of Sparganii Rhizoma-Curcumae Rhizoma-medicated serum on proliferation, apoptosis, and migration of human ectopic endometrial stromal cells: based on JAK2/STAT3 signaling pathway.
10.19540/j.cnki.cjcmm.20230118.401
- Author:
Yan WANG
1
;
Xiao-Bo NIE
2
;
Xia JIN
3
;
Jian-Ping WANG
3
;
Li-Hua LIU
3
;
Jiao LIU
4
Author Information
1. the Fourth Hospital of Shijiazhuang Shijiazhuang 050035, China Hebei Provincial Key Laboratory of Maternal Fetal Medicine Shijiazhuang 050035, China.
2. Shijiazhuang Medical College Shijiazhuang 050599, China.
3. the Fourth Hospital of Shijiazhuang Shijiazhuang 050035, China.
4. Hebei University of Chinese Medicine Shijiazhuang 050200, China.
- Publication Type:Journal Article
- Keywords:
Curcumae Rhizoma;
Janus kinase 2/signal transducer and activator of transcription 3(JAK2/STAT3) signaling pathway;
Sparganii Rhizoma;
compatibility of medicines;
ectopic endometrial stromal cells(ESCs)
- MeSH:
Female;
Humans;
Janus Kinase 2;
Caspase 3;
bcl-2-Associated X Protein;
Interleukin-6/genetics*;
Apoptosis;
Signal Transduction;
Cell Proliferation;
STAT3 Transcription Factor/genetics*
- From:
China Journal of Chinese Materia Medica
2023;48(12):3199-3206
- CountryChina
- Language:Chinese
-
Abstract:
Based on the Janus kinase 2/signal transducer and activator of transcription 3(JAK2/STAT3) signaling pathway, this study investigated the effect of medicated serum of Sparganii Rhizoma(SR) and Curcumae Rhizoma(CR) on the proliferation, apoptosis, migration, and secretion of inflammatory factors of ectopic endometrial stromal cells(ESCs). Specifically, human ESCs were primary-cultured. The effect of different concentration(5%, 10%, 20%) of SR-, CR-, and SR-CR combination-medicated serum, and AG490 solution(50 μmol·L~(-1)) on the proliferation of ESCs was detected by methyl thiazolyl tetrazolium(MTT) assay, and the optimal dose was selected accordingly for further experiment. The cells were classified into normal serum(NS) group, SR group(10%), CR group(10%), combination(CM) group(10%), and AG490 group. The apoptosis level of ESCs was detected by flow cytometry, and the migration ability was examined by wound healing assay. The secretion of interleukin(IL)-1β, IL-6, and tumor necrosis factor(TNF)-α was determined by enzyme-linked immunosorbent assay(ELISA). The protein levels of cysteinyl aspartate specific protei-nase-3(caspase-3), B-cell lymphoma(Bcl-2), and Bcl-2-associated X protein(Bax) and the levels of phosphorylated(p)-JAK2 and p-STAT3 were detected by Western blot. The results showed that the viability of ESCs cells was lowered in the administration groups compared with the blank serum group(P<0.01), especially the 10% drug-medicated serum, which was selected for further experiment. The 10% SR-medicated serum, 10% CR-medicated serum, and 10% CM-medicated serum could increase the apoptosis rate(P<0.01), up-regulate the protein expression of caspase-3 and Bax in cells(P<0.05 or P<0.01), down-regulate the expression of Bcl-2(P<0.01), decrease the cell migration rate(P<0.05 or P<0.01), and reduce the secretion levels of IL-1β, IL-6, and TNF-α(P<0.05 or P<0.01), and levels of p-JAK2 and p-STAT3(P<0.05 or P<0.01). Compared with the SR and CR groups, CM group showed low cell viability(P<0.01), high protein expression of caspase-3 and Bax(P<0.05 or P<0.01), and low protein expression of Bcl-2 and p-JAK2(P<0.05). After incubation with CM, the apoptosis rate was higher(P<0.05) and the migration rate was lower(P<0.01) than that of the CR group. The p-STAT3 protein level of CM group was lower than that of the RS group(P<0.05). The mechanism of SR, CR, and the combination underlying the improvement of endometriosis may be that they blocked JAK2/STAT3 signaling pathway, inhibited ESC proliferation, promoted apoptosis, weakened cell migration, and reduced the secretion of inflammatory factors. The effect of the combination was better than that of RS alone and CR alone.
